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Background/aim: The annual Hajj pilgrimage to Mecca, which attracts more than 3 million Muslim pilgrims from around the world,
has played a role in the global spread of meningococcal infection. We aimed to compare pharyngeal carriage of Neisseria meningitidis in
Hajj pilgrims before departure and after returning to Iran, Zahedan.
Materials and methods: This prospective and cross-sectional study was conducted among Hajj pilgrims in Zahedan (southeast Iran) in
2012. We studied all pilgrims who agreed to participate in this study and who met the inclusion criteria. Sampling was done by swabbing
the posterior pharyngeal wall through the mouth with direct plating or keeping transport time to below 5 h. Specific culture, oxidase
test, and carbohydrates tests were done on the positive samples.
Results: Among 422 pilgrims (42.2% male, 57.8% female; with age range 21–95 years), 6 (1.4%) were positive for N. meningitidis after
the Hajj pilgrimage. Nobody was positive before departure. During the Hajj 58.5% of the participants received antibiotics.
Conclusion: According to the results of our study, the prevalence of pharyngeal carriage of N. meningitidis in pilgrims after returning
to Zahedan was low (1.4%). The quadrivalent meningococcal vaccine and antibiotic therapy were effective in reducing the number of
carriers among pilgrims after travel.
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1. Introduction
Neisseria meningitidis is a member of the gram-negative
cocci and mostly its serogroups A, B, C, W135, and
Y contribute to human diseases (1). Up to 10% of the
world’s population may be asymptomatic carriers with
nasopharyngeal colonization, but higher rates can be seen
in crowded settings such as prisons, universities, schools,
immigrant camps, and military institutions (1,2). N.
meningitidis is responsible for meningitis and sepsis, and
delayed or undertreated cases are associated with mortality
rates above 50%. Moreover, even with prompt treatment,
meningococcal meningitis leads to death in 5% to 10% of
cases (2). Transmission occurs through breathing aerosols
by people who have had close or extended contact with
an infected patient, such as those in the same household
and shelters, roommates, and pilgrims. The development
of invasive MCD is dependent upon a wide variety of
bacterial, host, and environmental factors. Risk is highest
among travelers who have prolonged contact with local
populations in the meningitis belt during an epidemic (3).
The Hajj pilgrimage to Saudi Arabia has been associated
* Correspondence: nahid_sepehri@yahoo.com

with outbreaks of meningococcal disease in returning
pilgrims and those in contact with them (4). Every year,
about 3 million people from over 140 countries meet in
Medina and Mecca for nearly 30 days (5,6). The incidence
of meningococcal disease is several times higher in the
meningitis belt and Saudi Arabia than in Iran and other
countries, with periodic epidemics during the dry season
(December–June) (3–7).
In 1987, a N. meningitidis serogroup previously isolated
in East Asia and Europe occurred among the pilgrims,
and spread globally when the pilgrims returned to their
home countries (7–9). Then an outbreak of serogroup
W-135 MCD occurred in mid-March 2000 among Muslim
pilgrims returning from the pilgrimage to Mecca and those
in contact with them, with more than 340 cases being
reported from around the world (4,10). Recent studies
showed that W-135 and B were the commonest serogroups
causing meningococcal meningitis (11,12). The risk of
transmission increases owing to the fact that carriage
may last between 5 and 15 weeks (13–15). In the study by
Wilder-Smith et al., 15% of pilgrims were carriers of N.
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meningitidis following their return from pilgrimage, and
interestingly 55% of these carriers tested positive during
the next 6 months (16). Another study, by Ceyhan et al. in
2010 in Turkey, showed serogroup W135 to be responsible
for most carriage cases among pilgrims, despite their being
vaccinated with the quadrivalent vaccine. Moreover, the
carriers transmitted the pathogen to their family members,
and account for the main source of W135 in Turkey (17).
As there are few studies on pharyngeal carriage among
pilgrims in Iran, especially in this region (5), we decided to
study and to compare the carrier status of N. meningitidis
among pilgrims going to and pilgrims returning from the
Hajj.
2. Materials and methods
This cross-sectional and prospective study included Hajj
pilgrims from Zahedan in Iran in 2012. All pilgrims who
agreed to participate and who had not taken antibiotics
in the previous 7 days were enrolled in the study. The
pilgrims were tested twice: before departure from their
home country and after returning from the pilgrimage.
Pharyngeal swab sampling was performed in each pilgrim
at the waiting hall of the airport, and the swab was
maintained in Stuart Transport Medium until transmission
to the laboratory. The specimen was cultured on modified
Thayer-Martin and blood agar medium for 24 h. Following
Gram staining of the obtained colonies, gram-negative
diplococci were identified by oxidase and carbohydrate
consumption tests. The carrier status for N. meningitidis
was defined as a positive culture of the pharyngeal swab
sample for the organism. Then carrier rate was compared
in Hajj pilgrims before departure and after returning to
Zahedan, Iran.
2.1. Statistical analysis
The results were analyzed using SPSS 22.0 for Windows
to calculate significant differences and P ≤ 0.05 was
considered statistically significant.
3. Results
A total of 422 individuals were included in this study
(42.2% male, 57.8% female). The mean ± SD age of subjects
was 50.18 ± 11.09 years. Of these, 268 (63.5%) mentioned

a previous pilgrimage and 247 (58.5%) reported a history
of antibiotic use during the Hajj pilgrimage. Before-trip
sampling revealed 2 cases of Neisseria sicca (0.5%) and
11 cases of Moraxella catarrhalis (2.6%). However, no N.
meningitidis colony was grown on the culture. Post-trip
sampling showed 49 cases of N. sicca (11.6%), 15 cases
of M. catarrhalis (3.6%), and 6 cases of N. meningitidis
(1.4%) (Table). Among the patients with positive culture
of N. meningitides, 2 (33.3%) were aged < 40 years, 3 were
(50%) aged between 40 and 60 years, and one (16.7%) was
aged > 60 years. According to the chi-square test, there was
no significant relationship between age and carrier status
(P = 0.664). Most of the carriers were female (5 females,
83.3% vs. 1 male, 16.7%; P = 0.199). However, there was
no significant difference among carriers in terms of sex
distribution. Of the carrier patients, 3 individuals had
been on a previous pilgrimage (50%), which did not reveal
a statistically significant difference. On the other hand,
4 carriers (66.7%) reported a history of antibiotic use,
which did not show a significant relationship with carrier
status. Overall, of the 247 who reported previous antibiotic
use, 17% were carriers of N. meningitidis, N. sicca, and
M. catarrhalis, while of the 175 without previous use of
antibiotics, 28 (16%) were carriers of these organisms.
4. Discussion
Our study showed that, among 422, only 6 individuals
(1.4%) were positive for N. meningitidis after the Hajj
pilgrimage. Nobody was positive before departure.
Meningococcal meningitis is an endemic disease in eastern
Mediterranean countries, especially the sub-Saharan
meningitis belt. Sudden outbreaks of meningitis have been
observed in this region in the past. The annual incidence
rate of meningococcal meningitis has been reported
between 1 and 5 in every 100,000 people in the eastern
Mediterranean region. Nevertheless, the weaknesses of the
current health surveillance system of some countries and
underreporting to the World Health Organization should
be noted (4). Meningococcal meningitis is considered
a huge problem for the domestic health care system of
Saudi Arabia too, especially during the Hajj ceremony
and afterwards. The Hajj is an annual religious event that

Table. Prevalence of pharyngeal carriage of Neisseria meningitidis in pilgrims before and after Hajj
pilgrimage.
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Pharyngeal carriage

Neisseria meningitidis

Moraxella catarrhalis

Neisseria sicca

Before travel

N
0

%
0

N
11

%
2.6

N
2

%
0.5

After travel

N
6

%
1.4

N
15

%
3.6

N
49

%
11.6
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attracts a large number of pilgrims (over 2 million Muslims
from all over the world) to Saudi Arabia. This mass
gathering increases the risk of infectious disease outbreaks,
facilitated by large numbers of individuals staying in
confined areas for a short period of time. Following the
pilgrimages of 1987 and 1988, a large meningitis epidemic
occurred in some eastern Mediterranean countries. Saudi
Arabia experienced the first outbreak of the disease due
to the W135 serogroup during the Hajj ceremony in
2000, which repeated in 2001. Since then, the country
has mandated the quadrivalent vaccine (ACWY135)
for all pilgrims (11,12). Among the pilgrims in our
study who agreed to participate in sampling, none were
carriers before the pilgrimage, while 6 tested positive for
N. meningitidis after the pilgrimage. Such a carrier rate is
remarkably lower in relation to the carrier rate in society
and compared to previous studies. We did not find any
significant relationship between the carrier status and age,
sex, and previous history of pilgrimage, while 58% of the
pilgrims reported a previous history of antibiotic use. On
the other hand, N. sicca was the cause of postpilgrimage
carrier status in 11.6% of the pilgrims, followed by 3.6%
M. catarrhalis, and 1.4% N. meningitidis. In the study by
Alborzi et al. in Shiraz, which was conducted in 2008, the
carrier status of pilgrims was evaluated by nasopharyngeal
sampling before and after the pilgrimage. That study
revealed that administration of ciprofloxacin 500 mg, 24 h
before the trip, could decrease the carrier status from 8.2%
to zero (5). Another study by Husain et al., in 2010, was
conducted in 177 Hajj pilgrims. They found that there was

no throat colonization with N. meningitidis in any of the
throat swabs. Of the 177 pilgrims, 92% were vaccinated
with meningococcal quadrivalent vaccine and 83% of the
pilgrims had received one dose of ciprofloxacin before
leaving Mecca (8). Wilder-Smith et al. reported that 15%
of pilgrims were carriers of N. meningitidis following their
return from the pilgrimage (16). A study conducted by the
WHO in 2005 among pilgrims and their family contacts in
Morocco, 3 to 12 months after the Hajj, reported that 2.7%
of the specimens showed pharyngeal carriage of serogroup
W135 N. meningitidis (18). In our study, all 422 subjects
who underwent sampling had received the quadrivalent
meningococcal vaccine prior to the trip. Of these, 247
reported previous antibiotic usage during pilgrimage
(58.5%). The lower carrier status rate of our pilgrims is
probably due to previous antibiotic use. However, nobody
had received ciprofloxacin prophylaxis before leaving
Mecca in our study.
It is necessary that all the pilgrims receive the
quadrivalent meningococcal vaccine 10–14 days prior to
their trip to prevent infection with N. meningitidis.
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